|
ZNF526 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.276380E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.778450E-02 |
| Normal-vs-Stage2 |
1.053560E-01 |
| Normal-vs-Stage3 |
5.618600E-01 |
| Normal-vs-Stage4 |
7.141600E-01 |
| Stage1-vs-Stage2 |
9.684200E-01 |
| Stage1-vs-Stage3 |
7.184400E-02 |
| Stage1-vs-Stage4 |
5.349000E-01 |
| Stage2-vs-Stage3 |
1.199450E-01 |
| Stage2-vs-Stage4 |
6.334800E-01 |
| Stage3-vs-Stage4 |
5.156600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.404250E-01 |
| Normal-vs-AfricanAmerican |
3.058400E-02 |
| Normal-vs-Asian |
8.994200E-01 |
| Caucasian-vs-AfricanAmerican |
2.150800E-01 |
| Caucasian-vs-Asian |
5.324800E-01 |
| AfricanAmerican-vs-Asian |
2.414200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.352480E-02 |
| Normal-vs-Female |
3.684600E-01 |
| Male-vs-Female |
2.340400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.226820E-01 |
| Normal-vs-Extreme_Weight |
7.219400E-03 |
| Normal-vs-Obese |
6.507000E-01 |
| Normal-vs-Extreme_Obese |
3.876100E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.547200E-01 |
| Normal_Weight-vs-Obese |
8.607600E-02 |
| Normal_Weight-vs-Extreme_Obese |
2.122600E-01 |
| Extreme_Weight-vs-Obese |
2.996900E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.224400E-01 |
| Obese-vs-Extreme_Obese |
4.019500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.697990E-01 |
| Normal-vs-Age(41-60Yrs) |
6.589800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.699000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.135700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.232440E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.298400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.389530E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.400100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.573900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.233200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.764200E-02 |
| Normal-VS-Type2 PRCC |
3.654400E-02 |
| Normal-VS-KIRP CIMP |
1.031200E-01 |
| Normal-VS-Unclassified PRCC |
7.794200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.651800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.538100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.549900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.794300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.922400E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.274020E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.305700E-02 |
| Normal-vs-N1 |
8.290500E-02 |
| Normal-vs-N2 |
5.868400E-01 |
| N0-vs-N1 |
5.377000E-03 |
| N0-vs-N2 |
3.614600E-01 |
| N1-vs-N2 |
9.385800E-01 |
|
|
